未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏ACE-Breast-02: a randomized phase III trial of ARX788 versus lapatinib plus capecitabine for HER2-positive advanced breast cancerACE-Breast-02:一项比较ARX788与拉帕替尼联合卡培他滨治疗HER2阳性晚期乳腺癌的随机III期试验
Hu, Xichun; Zhang, Qingyuan; Wang, Leiping; Zhang, Jian; Ouyang, Quchang; Wang, Xiaojia; Li, Wei; Xie, Weimin; Tong, Zhongsheng; Wang, Shusen; Xu, Faliang; Sun, Tao; Liu, Wei; Chen, Zhendong; Wu, Jinsheng; Wang, Ying; Wang, Haixia; Yan, Min; Wang, Xinshuai; Wang, Jingfen; Cao, Feilin; Du, Yingying; Zhang, Yongqiang; Chen, Lilin; Lu, Ping; Sun, Sanyuan; Zhang, Ruiwen; Zang, Aimin; Nie, Xiuqing; Lei, Yuan
分享
收藏Innovative behavior and structural empowerment among the Chinese clinical nurses: the mediating role of decent work perception
Wang, Zhangyi; Yang, Li; Zhu, Yue; Tang, Xiaochun; Wang, Tingrui; Chen, Li; Li, Liping; Xie, Weimin; Peng, Jiaofeng; Yang, Jie; Long, Qianxiang; Lu, Feng; Wang, Yan; Shen, Huilong; Yin, Jun; Zhan, Xiaoping; Zhou, Huifang
分享
收藏Real-World Outcomes of Pyrotinib-Based Therapy for HER2-Positive Breast Cancer With Brain Metastases: A Multicentre, Retrospective Analysis基于吡罗替尼的疗法治疗HER2阳性伴脑转移乳腺癌的真实世界结局:一项多中心回顾性分析
Wu, Muxin; Lei, Sen; Tang, Yijing; He, Chengzu; Zhang, Jian; Lu, Xin'an; Tan, Aihua; Wang, Hongxue; Xie, Weimin
分享
收藏
分享
收藏The optimal neoadjuvant treatment regimen for HR+/HER2+breast cancer: a network meta-analysis
Wang, Hao; Liu, Shiwei; Yu, Miao; Mi, Kun; Mou, Exian; Xia, Li; Xie, Weimin; Tang, Hao; Feng, Yajing; Yu, Xin
分享
收藏Efficacy, Safety, and Immunogenicity of TQ-B211 (a Trastuzumab Biosimilar) Plus Docetaxel versus Herceptin® Plus Docetaxel for HER2-positive Metastatic Breast Cancer: a Double-blind, Randomised, Multicenter, Phase 3 Trial
Hu, Xichun; Zhang, Qingyuan; Wang, Shusen; Sun, Tao; Zeng, Xiaohua; Xie, Weimin; Tong, Zhongsheng; Cao, Hui; Xiong, Huihua; Wang, Xiuwen; Yang, Jin; Zhang, Shuqun; Wang, Ying; Hu, Chunhong; Lei, Kaijian; Ma, Binlin; Liu, Wei; Yu, Zhiyong; Peng, PeiJian; Yang, Hongwei; Yuan, Zhijun; Wang, Xiaojia; Wang, Xujuan; Wang, Hong; Shu, Yongqian; Li, Nanlin; Yue, Wenbin; Wang, Jingfen; Wang, Daqing; Luo, Zhiguo; Mo, Junyang; Li, Yarong; Sheng, Lili
分享
收藏Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trialPyrotinib联合卡培他滨治疗曲妥珠单抗耐药的HER2-positive晚期乳腺癌 (图片): 一项单臂多中心2期试验
Cao, Jun; Teng, Yuee; Li, Huiping; Zhang, Lili; Ouyang, Quchang; Xie, Weimin; Pan, Yueyin; Song, Zhenchuan; Ling, Xiaoling; Wu, Xiaohong; Xu, Jingwei; Li, Li; Ren, Liping; Wang, Hong; Zhou, Dongxian; Luo, Jing; Hu, Xichun
分享
收藏PyrotInib in combination with Capecitabine for trasTUzumab-REsistant, HER2-positive advanced breast cancer (PICTURE): a multicenter phase 2 trial
Hu, Xichun; Cao, Jun; Teng, Yue'e; Li, Hui-Ping; Zhang, Lili; Ouyang, Quchang; Xie, Weimin; Pan, Yueyin; Song, Zhenchuan; Ling, Xiaoling; Wu, Xiaohong; Xu, Jingwei; Li, Li; Ren, Liping; Wang, Hong; Zhou, Dongxian; Luo, Jing
分享
收藏
分享
收藏Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trialDalpiciclib或安慰剂联合氟维司群治疗激素受体阳性和HER2-negative晚期乳腺癌: 一项随机3期试验
Xu, Binghe; Zhang, Qingyuan; Zhang, Pin; Hu, Xichun; Li, Wei; Tong, Zhongsheng; Sun, Tao; Teng, Yuee; Wu, Xinhong; Ouyang, Quchang; Yan, Xi; Cheng, Jing; Liu, Qiang; Feng, Jifeng; Wang, Xiaojia; Yin, Yongmei; Shi, Yanxia; Pan, Yueyin; Wang, Yongsheng; Xie, Weimin; Yan, Min; Liu, Yunjiang; Yan, Ping; Wu, Fei; Zhu, Xiaoyu; Zou, Jianjun
分享
收藏
分享
收藏Mesenchymal Stem Cell-Secreted Exosome Promotes Chemoresistance in Breast Cancer via Enhancing miR-21-5p-Mediated S100A6 Expression
Luo, Tao; Liu, Qiaoyuan; Tan, Aihua; Duan, Lixia; Jia, Yuxian; Nong, Li; Tang, Jing; Zhou, Wenxian; Xie, Weimin; Lu, Yongkui; Yu, Qiang; Liu, Yan
分享
收藏Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53
Cao, Pengbo; Yang, Aiqing; Wang, Rui; Xia, Xia; Zhai, Yun; Li, Yuanfeng; Yang, Fei; Cui, Ying; Xie, Weimin; Liu, Ying; Liu, Taotao; Jia, Weihua; Jiang, Zhengwen; Li, Zhuo; Han, Yuqing; Gao, Chengming; Song, Qingfeng; Xie, Bobo; Zhang, Luo; Zhang, Hongxing; Zhang, Jinxu; Shen, Xizhong; Yuan, Yunfei; Yu, Feng; Wang, Ying; Xu, Jing; Ma, Yilong; Mo, Zengnan; Yu, Wuzhong; He, Fuchu; Zhou, Gangqiao
分享
收藏